Platform Based New Drug Pipeline Profile

Platform Tech NOX Apta-DC
Mode of Action Controlling oxidative stress via NOX inhibitor Inhibition of inflammation & fibrosis Targeting cancer cell by over expression of nucleolin
Technology World’s 1st NOXs HTS technology World’s 1st Aptamer-Drug Conjugation Technology
Indications Diabetic Complications
(Diabetic Nephropathy·Diabetic Retinopathy·wet-AMD·NASH·Arteriosclerosis)
Incurable Cancer Diseases
(Hemtaologic Malignancy · Pncreatic Cancer · Bladder Cancer · Liver Cancer)